LOMBOKita – 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, is pleased to announce that the 2013 Research License and Commercial Option Agreement between the Company and British American Tobacco (Investments) Limited (“BAT”) is now finished. BAT no longer has rights to any intellectual property […]
The post 22nd Century Now Free of Restrictive License Agreement With BAT appeared first on LOMBOKita.
The post 22nd Century Now Free of Restrictive License Agreement With BAT is republished from LOMBOKita